Abstract:Radiation therapy prior to surgery has increasingly become the standard of care for locally advanced prostate cancer, however tumor radioresistance remains a major clinical problem. While restoration of microRNA-145 (miR-145) expression reduces chemoradioresistance in glioblastoma and suppress prostate cancer proliferation, migration and invasion, the role of miR-145 in response to radiation therapy for prostate cancer is still unknown. The aim of this study was to investigate the role of miR-145 in determining the tumor response to radiation treatment in prostate cancer. Human prostate cancer cells LNCAP and PC3 were transfected with miR-145 mimic. Clonogenic assay was used to determine whether overexpression of miR-145 could alter radiation response in vitro. Immunofluorescence of γ-H2AX and flow cytometric analysis of phosphorylated histone H3 were performed to investigate the potential mechanisms contributing to the enhanced radiation-induced cell killing induced by miR-145. In addition, a qPCR-based array was used to detect the possible miR-145-mediated regulated genes involved. Tumor growth delay assays and survival curves were then analyzed in an animal model to investigate whether miR-145 induced radiosensitivity in vivo. Furthermore, miR-145 expression was assessed in 30 prostate tumor tissue biopsies taken prior to neoadjuvant radiotherapy using miRNA arrays. Our current study suggested that ectopic expression of miR-145 significantly sensitized prostate cancer cells to radiation and we used γ-H2AX phosphorylation as a surrogate marker of radiotherapy response versus miR-145 expression levels. We observed significantly more foci per cell in the group treated with miR-145 and radiation. In addition, mitotic catastrophe was significantly increased in cells receiving miR-145 and radiation. The above results suggest that miR-145 appears to reduced the efficiency of the repair of radiation-induced DNA double-strand breaks in cells. A detailed examination of the involvement of the DNA repair pathway showed that miR-145 reduced the expression of 10 genes involved in DNA repair according to a qPCR-based array data. Irradiation of subcutaneous PC3 tumors in mice treated with R11-miR-145 (a cellular permeable peptide, previously reported) resulted in an increase in radiation-induced tumor growth delay and lived the longest after combination treatment. Moreover, miR-145 expression was significantly increased in patients demonstrating good response (PSA < 2.0 ng/ml/year) to neoadjuvant radiotherapy, while expression of the miR-145-regulated DNA repair genes was significantly decreased. In conclusion, these data suggest a possible mechanism for miR-145 radiosensitivity, potentially through down regulating of DNA repair. This novel study shows a role for miR-145 in modulating radiosensitivity in vivo and highlights the need for further study investigating the potential role of miR-145 as both a predictive marker of response and a novel therapeutic agent with which to enhance the efficacy of radiation therapy.

Eef-2 Kinase-targeted Mir-449B Confers Radiation Sensitivity to Cancer Cells.

Therapeutic Delivery of Mir-29B Enhances Radiosensitivity in Cervical Cancer.

Mir-4796 Enhances the Sensitivity of Breast Cancer Cells to Ionising Radiation by Impairing the DNA Repair Pathway.

MicroRNA-449a Enhances Radiosensitivity by Downregulation of C-Myc in Prostate Cancer Cells

MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway.

MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR

Mir-205 Acts As a Tumour Radiosensitizer by Targeting ZEB1 and Ubc13

miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ

MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma

MiR-450b-5p enhances the radiosensitivity of HR+ and HER2− breast cancer by targeting CDK6

Radiation-induced Mir-208A Increases the Proliferation and Radioresistance by Targeting P21 in Human Lung Cancer Cells.

Ectopic Expression of Mir-34A Enhances Radiosensitivity of Non-Small Cell Lung Cancer Cells, Partly by Suppressing the LyGDI Signaling Pathway.

MicroRNA-298 determines the radio-resistance of colorectal cancer cells by directly targeting human dual-specificity tyrosine(Y)-regulated kinase 1A

Role and Mechanism of Mir-4778-3p and Its Targets NR2C2 and Med19 in Cervical Cancer Radioresistance.

Mir-144-5p Enhances The Radiosensitivity Of Non-Small-Cell Lung Cancer Cells Via Targeting Atf2

MiR-181a Confers Resistance of Cervical Cancer to Radiation Therapy Through Targeting the Pro-Apoptotic PRKCD Gene

Mir-410 Induces Both Epithelial–mesenchymal Transition and Radioresistance Through Activation of the PI3K/mTOR Pathway in Non-Small Cell Lung Cancer

IKKα-mediated Biogenesis of Mir-196A Through Interaction with Drosha Regulates the Sensitivity of Cancer Cells to Radiotherapy.

MicroRNA-144 Affects Radiotherapy Sensitivity by Promoting Proliferation, Migration and Invasion of Breast Cancer Cells.

MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer

MicroRNA-381 Increases Radiosensitivity in Esophageal Squamous Cell Carcinoma.